Login / Signup

Early feasibility study with an implantable near-infrared spectroscopy sensor for glucose, ketones, lactate and ethanol.

Francesca De RidderRie BraspenningJuan S OrdonezGijs KlarenbeekPatrick LauwersKristien J LedeganckDanaë DelbekeChristophe E M De Block
Published in: PloS one (2024)
Clinical trial identifier: NCT04782934.
Keyphrases
  • clinical trial
  • phase ii
  • blood glucose
  • open label
  • double blind
  • study protocol
  • type diabetes
  • metabolic syndrome
  • placebo controlled